AI‐Assisted Tumor Boundary Delineation via Targeted Ultrasmall Iron Oxide Nanoprobe for High‐Contrast HER2‐Positive Tumor Imaging
Advanced Science · 2026-11 · 13 (63)
DOI: 10.1002/advs.77355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.08.2026. Verfasst von Jiaying Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Engineering, Shantou University, Shantou, People's Republic of China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Erb-b2 Receptor Tyrosine Kinases, Contrast Media, Breast Neoplasms. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Province Natural Science Foundation, Li Ka Shing Foundation STU-GTIIT Joint-research Grant.
Abstract (Originalsprache)
Breast cancer continues to be a leading cause of cancer‐related mortality in women globally, where precise diagnosis and clear tumor demarcation are critical for effective treatment. Herein, we developed a strategic platform that combines a novel ultrasensitive magnetic resonance (MR) contrast agent with deep learning to significantly enhance the tumor‐to‐normal ratio (TNR). We designed ultrasmall iron oxide nanoparticles (USIO NPs) conjugated with trastuzumab (Tmab) for targeted MR imaging of HER2‐positive breast cancer. The USIO@Tmab nanoprobe demonstrated excellent HER2 specificity and pH‐responsive activation. The relaxivity of the nanoprobe shifted from a low T 1 ‐weighted intensity (r 1 = 1.43 mM − 1 s − 1 ) under physiological conditions to an enhanced value (r 1 = 4.07 mM − 1 s − 1 ) in the acidic tumor microenvironment due to the detachment of Tmab protein. Additionally, we employed the 3D nnU‐Net deep learning framework as a post‐processing visualization aid to enhance tumor boundary detection via image fusion, rather than to amplify the underlying MRI signal. This approach yielded high segmentation accuracy, with an Intersection‐over‐Union (IoU) of 0.88 and a Dice coefficient of 0.93. This strategy provided an additional 2.59‐fold increase in TNR and enabled the reconstruction of three‐dimensional (3D) tumor models, offering clinicians an intuitive visualization of tumor structure for precise diagnosis and surgical guidance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Engineering, Shantou University, Shantou, People's Republic of China.
- Department of Radiology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
ORCID-Profile: Xiangyuan Ma, Zhongling Wang, Benqing Zhou
Förderung
- National Natural Science Foundation of China
- Guangdong Province Natural Science Foundation
- Li Ka Shing Foundation STU-GTIIT Joint-research Grant
Zitieren
APA
Zheng, J., Zhu, Y., Li, X., Dai, S., Ma, X., Lu, H., Wang, Z., & Zhou, B. (2026). AI‐Assisted Tumor Boundary Delineation via Targeted Ultrasmall Iron Oxide Nanoprobe for High‐Contrast HER2‐Positive Tumor Imaging. Advanced Science, 13(63). https://doi.org/10.1002/advs.77355
Vancouver
Zheng J, Zhu Y, Li X, Dai S, Ma X, Lu H, et al. AI‐Assisted Tumor Boundary Delineation via Targeted Ultrasmall Iron Oxide Nanoprobe for High‐Contrast HER2‐Positive Tumor Imaging. Advanced Science. 2026;13(63). doi:10.1002/advs.77355
BibTeX
@article{Zheng2026,
author = {Zheng, Jiaying and Zhu, Yi and Li, Xinrui and Dai, Sunxian and Ma, Xiangyuan and Lu, Hongwei and Wang, Zhongling and Zhou, Benqing},
title = {AI‐Assisted Tumor Boundary Delineation via Targeted Ultrasmall Iron Oxide Nanoprobe for High‐Contrast HER2‐Positive Tumor Imaging},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {63},
doi = {10.1002/advs.77355}
}
EUVIMED